Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells
Abstract Fibroblast growth factors (FGFs) control various cellular functions through fibroblast growth factor receptor (FGFR) activation, including proliferation, differentiation, migration, and survival. FGFR amplification in ER + breast cancer patients correlate with poor prognosis, and FGFR inhib...
Main Authors: | Feng Chi, Jason I. Griffiths, Aritro Nath, Andrea H. Bild |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | Breast Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13058-024-01808-7 |
Similar Items
-
FGF21 prevents neuronal cell ferroptosis after spinal cord injury by activating the FGFR1/β-Klotho pathway
by: Tianli Xu, et al.
Published: (2023-10-01) -
Recent Advances in Tumor Therapy Targeting FGFR
by: ZHANG Jing, et al.
Published: (2022-02-01) -
Clinical advances and challenges in targeting FGF/FGFR signaling in lung cancer
by: Mei Peng, et al.
Published: (2024-11-01) -
Therapies targeting triple-negative breast cancer: a perspective on anti-FGFR
by: Jinhao Chen, et al.
Published: (2025-03-01) -
Novel Regulatory Factors and Small-Molecule Inhibitors of FGFR4 in Cancer
by: Yanan Liu, et al.
Published: (2021-04-01)